Arlington Heights, IL, United States of America

Teresa (Iok-Chan) Ng

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Abbvie Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teresa (Iok-Chan) Ng. Retrieved from https://idiyas.com/inventor/teresa-iok-chan-ng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Teresa (Iok-Chan) Ng: Innovator in Antibody Research

Introduction

Teresa (Iok-Chan) Ng is a prominent inventor based in Arlington Heights, IL (US). She has made significant contributions to the field of biomedical research, particularly in the development of antibodies for therapeutic use. Her work is crucial in addressing health challenges, including HIV infection.

Latest Patents

Teresa holds a patent for anti-alpha-4-beta-7 antibodies. This patent provides innovative solutions by offering antibodies that bind to human alpha-4-beta-7. The methods of making these antibodies and their applications in treating patients with HIV infection are detailed in her patent. She has 1 patent to her name.

Career Highlights

Teresa is currently employed at AbbVie Inc., a leading biopharmaceutical company. Her role involves extensive research and development in antibody therapies. Her work has positioned her as a key figure in the fight against viral infections.

Collaborations

Throughout her career, Teresa has collaborated with notable colleagues, including Jing Min and Lorenzo Benatuil. These partnerships have enhanced her research efforts and contributed to the advancement of therapeutic antibodies.

Conclusion

Teresa (Iok-Chan) Ng is a dedicated inventor whose work in antibody research is making a significant impact in the medical field. Her innovative approaches and collaborations continue to pave the way for advancements in treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…